共 69 条
[1]
Motzer RJ(2007)Sunitinib versus interferon alfa in metastatic renal cell carcinoma N Engl J Med 356 115-124
[2]
Hutson TE(2007)Sorafenib in advanced clear cell renal cell carcinoma N Engl J Med 356 125-134
[3]
Tomczak P(2007)Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Lancet 370 2103-2111
[4]
Escudier B(1992)Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2 Ann Oncol 3 475-480
[5]
Eisen T(2002)Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d’Immunotherapie Ann Oncol 13 1460-1468
[6]
Stadler WM(2002)Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma J Clin Oncol 20 289-296
[7]
Escudier B(2003)Metastatic renal carcinoma comprehensive prognostic system Br J Cancer 88 348-353
[8]
Pluzanska A(2003)Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 215-219
[9]
Koralewski P(1998)Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival Int J Oncol 13 589-594
[10]
Palmer PA(2005)Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer Dis Esophagus 18 146-150